3 completed, 1 terminated. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Terminated 1 |
Follow Recurrent Vaginal Cancer: new trials by email Literature Review of Recurrent Vaginal Cancer trials Research Report on Recurrent Vaginal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer Durvalumab, Tremelimumab, Radiation Therapy - Recurrent Gynecological Cancer, Metastatic Cervical Cancer | Phase 1 | Terminated | Dana-Farber Cancer Institute | 16 | 2018-06-01 | 2025-05-31 |
| Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer stereotactic body radiation therapy, carboplatin, gemcitabine hydrochloride - Leydig Cell Tumor, Ovarian Sarcoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 12 | 2012-05-01 | 2015-08-04 |
| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies triapine, laboratory biomarker analysis, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2006-03-01 | 2013-01-11 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
Uterine Cervical Neoplasms (4) · Vaginal Neoplasms (4) · Vulvar Neoplasms (4) · Carcinoma, Ovarian Epithelial (3) · Endometrial Neoplasms (3) · Fallopian Tube Neoplasms (2) · Adenocarcinoma, Follicular (1) · Adrenocortical Carcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Islet Cell (1)
Adnexal Diseases (4) · Endocrine Gland Neoplasms (4) · Endocrine System Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Gonadal Disorders (4) · Neoplasms (4) · Neoplasms by Site (4) · Ovarian Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Uterine Cervical Diseases (4)
3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Brachytherapy (1) · Carboplatin (1) · Cisplatin (1) · Gemcitabine (1) · Interleukin-12 (1) · Interleukin-12 Subunit p35 (1) · Pharmacogenomic Testing (1) · Radiosurgery (1) · Radiotherapy (1) · Therapeutics (1) · Trastuzumab (1) · durvalumab (1) · tremelimumab (1)
National Cancer Institute (NCI) (2) · Case Comprehensive Cancer Center (1) · Dana-Farber Cancer Institute (1)
United States (4)
Charles Kunos (1) · Martin King, MD, PhD (1) · Steven Waggoner, MD (1) · William Carson (1)
U01CA062502 (1), U01CA076576 (1)